Brett Schrand

Research Assistant Professor

  • 202 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Brett Schrand is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 202 Citations
  • 13 Article
  • 1 Comment/debate

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L. Y., Ling, X., Caruso, H., Zhou, S., Wang, Y. A., Fuller, G. N., Huse, J., Gilboa, E., Kang, N., Huang, X., Verhaak, R., Li, S. & Heimberger, A. B., Jan 2 2019, In : Journal of Clinical Investigation. 129, 1, CI121266.

Research output: Contribution to journalArticle

  • 20 Scopus citations

    Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

    Garrido, G., Schrand, B., Rabasa, A., Levay, A., D’Eramo, F., Berezhnoy, A., Modi, S., Gefen, T., Marijt, K., Doorduijn, E., Dudeja, V., van Hall, T. & Gilboa, E., Dec 1 2019, In : Nature communications. 10, 1, 3773.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity

    Schrand, B., Clark, E., Levay, A., Capote, A. R., Martinez, O., Brenneman, R., Castro, I. & Gilboa, E., Dec 1 2018, In : Nature Communications. 9, 1, 3348.

    Research output: Contribution to journalArticle

  • Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition

    Puplampu-Dove, Y., Gefen, T., Rajagopalan, A., Muheramagic, D., Schrand, B. & Gilboa, E., Feb 14 2018, (Accepted/In press) In : OncoImmunology.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity

    Rajagopalan, A., Berezhnoy, A., Schrand, B., Puplampu-Dove, Y. & Gilboa, E., Jan 4 2017, In : Molecular Therapy. 25, 1, p. 54-61 8 p.

    Research output: Contribution to journalArticle

  • 18 Scopus citations